Novel targets for AML

Ramiro Garzon

There are currently a number of ongoing clinical trials for acute myeloid leukemia (AML) that are targeting nuclear exporters. In this video, recorded at the International Conference on Acute Myeloid Leukaemia 2017 in Estoril, Portugal by the European School of Hematology (ESH), Ramiro Garzon, MD, from Ohio State University, Columbus, OH, discusses the promise of these novel agents.

Share this video